The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, placing it in the mid-priced tier for Rx devices. In HearAdvisor's lab testing, it earned a SoundScore of 1.70/5 and a D grade, ranking near the bottom of the prescription hearing aid category.
Performance testing revealed significant challenges across key metrics. Speech understanding in both quiet and noisy environments measured well below average, which limits the device's effectiveness in everyday listening situations. Own-voice comfort also scored poorly, with occlusion-related issues persisting across both fit conditions. The one bright spot was feedback handling, which performed above average with no stability concerns during standardized challenge testing.
The Groove's positioning in the market is difficult to justify given its performance. At $795, several lower-priced alternatives delivered better sound performance in our lab testing, including devices at a fraction of the cost. The MDHearing Volt at $397 and even the Audien Hearing Atom at $99 both achieved higher overall scores.
This device may appeal to those specifically seeking an Otofonix product with rechargeable batteries, but consumers prioritizing speech clarity and overall sound quality should explore alternatives. The limited improvement from initial to tuned fitting—with the tuned condition actually scoring slightly lower—suggests the device has fundamental gain and processing limitations that professional adjustment cannot fully overcome.
